Thus, the reduction in liver metastasis observed in mice injected with Afadin-deficient breast cancer cells is similar to that observed in mice injected with Claudin-2 knockdown cells (Fig. 2), and both Afadin isoforms contribute to the formation of breast cancer liver metastases. The gene discussed is CLDN2; the disease is breast carcinoma.